Literature DB >> 19715666

Essential role of STIM1 in the development of cardiomyocyte hypertrophy.

Takayoshi Ohba1, Hiroyuki Watanabe, Manabu Murakami, Takako Sato, Kyoichi Ono, Hiroshi Ito.   

Abstract

Store-operated Ca(2+) entry (SOCE) through transient receptor potential (TRP) channels is important in the development of cardiac hypertrophy. Recently, stromal interaction molecule 1 (STIM1) was identified as a key regulator of SOCE. In this study, we examined whether STIM1 is involved in the development of cardiomyocyte hypertrophy. RT-PCR showed that cultured rat cardiomyocytes constitutively expressed STIM1. Endothelin-1 (ET-1) treatment for 48h enhanced TRPC1 expression, SOCE, and nuclear factor of activated T cells activation without upregulating STIM1. However, the knockdown of STIM1 suppressed these effects, thereby preventing a hypertrophic response. These results suggest that STIM1 plays an essential role in the development of cardiomyocyte hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19715666     DOI: 10.1016/j.bbrc.2009.08.117

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

1.  Store-operated calcium entry is present in HL-1 cardiomyocytes and contributes to resting calcium.

Authors:  Chad D Touchberry; Chris J Elmore; Tien M Nguyen; Jon J Andresen; Xiaoli Zhao; Matthew Orange; Noah Weisleder; Marco Brotto; William C Claycomb; Michael J Wacker
Journal:  Biochem Biophys Res Commun       Date:  2011-11-06       Impact factor: 3.575

Review 2.  Transcriptional mechanisms regulating Ca(2+) homeostasis.

Authors:  Michael F Ritchie; Yandong Zhou; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2010-11-13       Impact factor: 6.817

3.  Critical role for stromal interaction molecule 1 in cardiac hypertrophy.

Authors:  Jean-Sébastien Hulot; Jérémy Fauconnier; Deepak Ramanujam; Antoine Chaanine; Fleur Aubart; Yassine Sassi; Sabine Merkle; Olivier Cazorla; Aude Ouillé; Morgan Dupuis; Lahouaria Hadri; Dongtak Jeong; Silke Mühlstedt; Joachim Schmitt; Attila Braun; Ludovic Bénard; Youakim Saliba; Bernhard Laggerbauer; Bernhard Nieswandt; Alain Lacampagne; Roger J Hajjar; Anne-Marie Lompré; Stefan Engelhardt
Journal:  Circulation       Date:  2011-08-01       Impact factor: 29.690

Review 4.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

Review 5.  STIM proteins: dynamic calcium signal transducers.

Authors:  Jonathan Soboloff; Brad S Rothberg; Muniswamy Madesh; Donald L Gill
Journal:  Nat Rev Mol Cell Biol       Date:  2012-09       Impact factor: 94.444

Review 6.  Molecular physiology and pathophysiology of stromal interaction molecules.

Authors:  Heather A Nelson; Michael W Roe
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-24

7.  Conformation of ryanodine receptor-2 gates store-operated calcium entry in rat pulmonary arterial myocytes.

Authors:  Amanda H Y Lin; Hui Sun; Omkar Paudel; Mo-Jun Lin; James S K Sham
Journal:  Cardiovasc Res       Date:  2016-03-24       Impact factor: 10.787

8.  Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes.

Authors:  Xiaoyuan Zhu-Mauldin; Susan A Marsh; Luyun Zou; Richard B Marchase; John C Chatham
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

9.  SOX2-mediated inhibition of miR-223 contributes to STIM1 activation in phenylephrine-induced hypertrophic cardiomyocytes.

Authors:  Zhi-Hong Zhao; Jun Luo; Hai-Xia Li; Sai-Hua Wang; Xin-Ming Li
Journal:  Mol Cell Biochem       Date:  2017-11-07       Impact factor: 3.396

Review 10.  What role for store-operated Ca²⁺ entry in muscle?

Authors:  Mohamed Trebak; Wei Zhang; Brian Ruhle; Matthew M Henkel; José C González-Cobos; Rajender K Motiani; Judith A Stolwijk; Rachel L Newton; Xuexin Zhang
Journal:  Microcirculation       Date:  2013-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.